Integer (NYSE:ITGR) vs. Profusa (NASDAQ:PFSA) Head to Head Contrast

Integer (NYSE:ITGR) and Profusa (NASDAQ:PFSA) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Integer and Profusa, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0	13	1	0	2.07
Profusa	1	0	0	0	1.00

Integer presently has a consensus price target of $109.86, suggesting a potential downside of 13.32%. Given Integer’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Integer is more favorable than Profusa.

Valuation & Earnings

This table compares Integer and Profusa”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85 billion	2.32	$102.81 million	$3.66	34.63
Profusa	$100,000.00	5.18	-$35.82 million	($5,619.96)	-0.00

Integer has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Integer and Profusa’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Profusa	N/A	N/A	-1,731.09%

Institutional & Insider Ownership

99.3% of Integer shares are owned by institutional investors. Comparatively, 9.8% of Profusa shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 15.0% of Profusa shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Integer has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Profusa has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.

Summary

Integer beats Profusa on 11 of the 13 factors compared between the two stocks.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

About Profusa

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.